Johnson & Johnson Launches Innovative ACUVUE OASYS MAX Lens for Astigmatism and Presbyopia
- Johnson & Johnson launches ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, a first daily disposable lens for dual vision needs.
- The lens offers clear vision and all-day comfort, enhancing users' quality of life and showcasing Johnson & Johnson's innovation.
- ACUVUE OASYS MAX reinforces Johnson & Johnson's leadership in contact lenses, addressing specific vision needs with advanced technology.
Johnson & Johnson Launches Groundbreaking Contact Lens for Astigmatism and Presbyopia
Johnson & Johnson, a leader in eye health, announces the launch of the ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, representing a noteworthy advancement in the realm of contact lens technology. This innovative lens is the first daily disposable option specifically tailored for individuals coping with both astigmatism and presbyopia, a common age-related vision condition. Designed to deliver crisp and clear vision across all distances and under various lighting conditions, the ACUVUE OASYS MAX ensures all-day comfort, thereby reinforcing Johnson & Johnson’s commitment to enhancing the quality of life for its users.
The introduction of this multifocal toric contact lens is a significant step in addressing the unmet needs of patients with complex visual requirements. Peter Menziuso, Company Group Chairman of Vision at Johnson & Johnson, expresses excitement about the launch, highlighting its role in building upon the company’s legacy of innovation. He emphasizes that clear vision is essential for individuals to fully engage in their daily lives, and this product aims to provide millions with a superior ACUVUE experience. The lens not only showcases the brand's dedication to eye health but also reflects ongoing advancements in optical and material science that Johnson & Johnson champions.
The ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM is currently available in the U.S. and Canada, with additional launches planned for later in the summer. This product further solidifies ACUVUE's position as the leading contact lens brand worldwide. By focusing on innovative solutions that cater to specific vision needs, Johnson & Johnson is setting a new standard in the contact lens industry and emphasizing its commitment to improving patients' lives through cutting-edge eye care technology.
In other news, Woody Johnson, owner of the New York Jets, is poised to acquire a 43 percent stake in Crystal Palace, a move that signifies his growing footprint in the sports industry. This acquisition, valued at approximately £190 million ($254 million), aligns with a broader trend of sports owners diversifying their investments across multiple leagues. Johnson's extensive experience in sports ownership and his previous attempts to enter European soccer reflect a strategic expansion that could enhance Crystal Palace's competitiveness in upcoming seasons.
The potential impact of Johnson's investment on Crystal Palace's prospects is notable, especially as the club seeks to secure a stronger position in European competitions. The deal requires approval from the Premier League, but given Johnson's pedigree, this process is expected to proceed smoothly.
